Hannah Valantine is Director at BridgeBio Pharma, Inc. (BBIO). They have made 7 open-market trades across 1 company since 2021, most recently 2026-07-16.
CIK 0001855608
4 open-market purchases totalling $105K since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDNA | 36,686 | $2.3M |
| BBIO | 9,259 | $615K |
| PACB | 22,821 | $40K |
| Total | $3.0M |
Shares reported on the most recent Form 4, priced at the 2026-07-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDNA | SELL · 10b5-1 | 2026-07-16 | 2026-07-17 | $36.15 | $1.0M | -8.6% | +19.8% | +72.2% |
| BBIO | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $68.25 | $342K | +11.4% | +20.2% | -1.0% |
| CDNA | SELL · 10b5-1 | 2026-06-15 | 2026-06-16 | $23.11 | $280K | +25.8% | +73.3% | +125.4% |
| BBIO | SELL | 2026-03-10 | 2026-03-12 | $72.00 | $624K | -0.4% | +13.2% | -2.1% |
| BBIO | SELL · 10b5-1 | 2026-02-27 | 2026-03-03 | $67.41 | $1.7M | +6.8% | +12.5% | +0.6% |
| BBIO | SELL | 2025-11-12 | 2025-11-14 | $66.07 | $3.4M | +9.2% | +13.4% | +15.8% |
| BBIO | SELL | 2025-06-26 | 2025-06-30 | $44.04 | $358K | +8.1% | +6.1% | +20.8% |
| CDNA | SELL · 10b5-1 | 2025-06-18 | 2025-06-23 | $19.16 | $405K | +0.6% | -31.4% | -21.6% |
| BBIO | SELL · 10b5-1 | 2025-06-10 | 2025-06-11 | $40.00 | $172K | +14.0% | +19.2% | +37.2% |
| BBIO | SELL · 10b5-1 | 2025-03-06 | 2025-03-10 | $32.58 | $839K | +8.1% | +4.8% | +24.4% |
| BBIO | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $37.75 | $220K | +1.3% | -17.6% | -16.1% |
| BBIO | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $37.97 | $221K | -3.9% | -4.3% | -33.5% |
| BBIO | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $36.12 | $211K | +1.1% | -6.1% | -30.5% |
| BBIO | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $30.00 | $87K | -1.7% | +31.6% | +34.3% |
| BBIO | BUY | 2021-12-29 | 2022-01-03 | $14.23 | $25K | -24.9% | -40.7% | -30.5% |
| BBIO | BUY | 2021-12-29 | 2025-06-30 | $14.24 | $25K | +8.1% | +6.1% | +20.8% |
| BBIO | BUY | 2021-12-28 | 2025-06-30 | $13.16 | $10K | +8.1% | +6.1% | +20.8% |
| BBIO | BUY | 2021-12-28 | 2024-02-13 | $12.96 | $44K | +1.4% | -20.5% | -17.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.